ReShape Duo Delivers Weight Loss In Sham-Controlled Pivotal Trial

The REDUCE US pivotal trial of ReShape Medical’s Duo dual intragastric balloon weight-loss therapy is the first prospective randomized pivotal trial of a device to treat obesity to meet its primary efficacy endpoints, according to the San Clemente, California, company.

More from Archive

More from Medtech Insight